Austin Health

Title
Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT Study.
Publication Date
2020-09-03
Author(s)
Yates, Max
Owen, Claire E
Muller, Sara
Graham, Karly
Neill, Lorna
Twohig, Helen
Boers, Maarten
Pujades Rodriguez, Mar
Goodman, Susan M
Cheah, Jonathan
Dejaco, Christian
Mukhtyar, Chetan
Nielsen, Berit Dalsgaard
Robson, Joanna
Simon, Lee S
Shea, Beverley
Mackie, Sarah L
Hill, Catherine L
Subject
DESCRIPTIVE QUALITATIVE STUDY
OUTCOME MEASURES
POLYMYALGIA RHEUMATICA
Type of document
Journal Article
OrcId
0000-0003-3977-8920
0000-0002-2694-5411
0000-0001-6645-5751
0000-0001-8781-1268
0000-0002-6969-283X
0000-0002-1375-1028
0000-0003-1197-7864
0000-0003-1828-7284
0000-0002-0173-0668
0000-0002-9771-6667
0000-0001-6291-157X
0000-0002-7939-5978
0000-0003-2483-5873
0000-0001-8289-4922
DOI
10.3899/jrheum.190575
Abstract
To survey participants with polymyalgia rheumatica (PMR) to evaluate the face validity, acceptability, and domain match of proposed candidate outcome measures. A structured, online, anonymous survey was disseminated by patient support groups through their networks and online forums. The candidate outcome measures comprised (1) visual analog scale (VAS) and numerical rating score (NRS) to assess pain; (2) VAS, NRS, and duration to assess stiffness; (3) the modified Health Assessment Questionnaire and Health Assessment Questionnaire Disability Index to assess physical function; and (4) C-reactive protein and erythrocyte sedimentation rate to assess inflammation. Free-text answers were analyzed using descriptive thematic analysis to determine respondents' views of the candidate instruments. Seventy-eight people with PMR from 6 countries (UK, France, USA, Canada, Australia, and New Zealand) participated in the survey. Most respondents agreed candidate instruments were acceptable or "good to go." Free-text analysis identified 5 themes that participants considered inadequately covered by the proposed instruments. These related to (1) the variability, context, and location of pain; (2) the variability of stiffness; (3) fatigue; (4) disability; and (5) the correlation of inflammatory marker levels and severity of symptoms, sometimes reflecting disease activity and other times not. Participants reported additional aspects of their experience that are not covered by the proposed instruments, particularly for the experience of stiffness and effect of fatigue. New patient-reported outcome measures are required to increase the relevance of results from clinical trials to patients with PMR.
Link
Citation
The Journal of Rheumatology 2020; 47(9): 1379-1384
Jornal Title
The Journal of Rheumatology
ISSN
0315-162X

Files:

NameSizeformatDescriptionLink